TOMASSETTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 6.087
AS - Asia 4.884
EU - Europa 4.047
SA - Sud America 313
AF - Africa 261
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 15.598
Nazione #
US - Stati Uniti d'America 6.035
VN - Vietnam 1.567
CN - Cina 1.268
GB - Regno Unito 1.254
SG - Singapore 1.207
DE - Germania 542
SE - Svezia 416
IT - Italia 412
UA - Ucraina 379
FR - Francia 302
HK - Hong Kong 256
RU - Federazione Russa 237
BR - Brasile 229
IN - India 225
IE - Irlanda 134
JP - Giappone 90
ZA - Sudafrica 87
EE - Estonia 85
CH - Svizzera 81
BD - Bangladesh 73
FI - Finlandia 70
TG - Togo 60
CI - Costa d'Avorio 42
KR - Corea 42
AR - Argentina 41
NL - Olanda 40
SC - Seychelles 28
NG - Nigeria 24
BE - Belgio 22
CA - Canada 22
TH - Thailandia 19
JO - Giordania 17
MX - Messico 17
EC - Ecuador 16
PH - Filippine 15
PL - Polonia 15
TW - Taiwan 15
UZ - Uzbekistan 15
AT - Austria 14
TR - Turchia 13
IQ - Iraq 11
BG - Bulgaria 10
GR - Grecia 10
PK - Pakistan 8
ID - Indonesia 7
CL - Cile 6
IR - Iran 6
LB - Libano 6
PY - Paraguay 6
SA - Arabia Saudita 6
CO - Colombia 5
EG - Egitto 5
MA - Marocco 5
MY - Malesia 5
RO - Romania 5
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
ES - Italia 3
HU - Ungheria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
AZ - Azerbaigian 2
ET - Etiopia 2
HR - Croazia 2
JM - Giamaica 2
NP - Nepal 2
PR - Porto Rico 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.598
Città #
Southend 1.126
Singapore 794
Fairfield 618
Ashburn 540
Chandler 388
Ho Chi Minh City 316
San Jose 312
Seattle 295
Woodbridge 290
Wilmington 280
Hanoi 273
Jacksonville 267
Dong Ket 258
Houston 255
Santa Clara 253
Hong Kong 251
Cambridge 229
Princeton 224
Ann Arbor 180
Beijing 155
Hefei 141
Boardman 135
Dublin 133
Lauterbourg 120
Padova 105
Westminster 103
Nanjing 102
Los Angeles 84
Tokyo 82
Berlin 79
Bern 74
Council Bluffs 72
Helsinki 70
Lomé 60
Milan 59
Da Nang 53
Shenyang 53
Nanchang 50
Saint Petersburg 49
New York 48
Mülheim 47
Bologna 46
Jinan 46
Dallas 44
Abidjan 42
San Diego 40
Haiphong 39
Medford 36
Seoul 35
Buffalo 34
Changsha 34
Tianjin 34
São Paulo 33
Guangzhou 30
Shanghai 28
Hebei 27
Redondo Beach 26
Des Moines 25
Abeokuta 24
Mahé 24
Frankfurt am Main 22
Biên Hòa 18
Fuzhou 18
Jiaxing 18
Wuhan 18
Amman 17
Ningbo 17
Phoenix 17
Brussels 16
Turin 16
Washington 16
Bremen 15
Hải Dương 15
Norwalk 15
Yubileyny 15
Bengaluru 14
Hangzhou 14
Zhengzhou 14
Verona 13
Ha Long 12
Haikou 12
Shijiazhuang 12
Dearborn 11
Paris 11
Can Tho 10
Falkenstein 10
Olalla 10
Quận Bình Thạnh 10
Rome 10
Sofia 10
Atlanta 9
Chicago 9
Florence 9
London 9
Ninh Bình 9
San Francisco 9
Taizhou 9
Vienna 9
Vinh 9
Brooklyn 8
Totale 10.185
Nome #
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. 329
Basis for treatment of functioning neuroendocrine tumours. 234
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 227
Chromogranin A: is it a useful marker of neuroendocrine tumors? 225
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 225
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 222
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 222
Endocrine pancreatic tumors: factors correlated with survival. 218
A case of primary pancreatic lymphoma. 216
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 210
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 207
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 204
Exocrine pancreatic function after alcoholic or biliary acute pancreatitis 202
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 199
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 196
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 196
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. 193
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 190
Endocrine tumors of the ileum: factors correlated with survival. 188
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 187
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 186
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. 180
Il percorso diagnostico preoperatorio e la preparazione all'intervento chirurgico 180
Capsule endoscopy for the diagnosis of midgut neuroendocrine carcinoma. 179
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. 179
Medical treatment of endocrine gastroenteropancreatic tumors. 176
Zollinger-Ellison syndrome. Diagnosis and therapy. 175
Water-related techniques in colonoscopy: the end justifies the means! 174
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 171
Clinical approach to diarrhea 171
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 168
Sedation during colonoscopy and the benefits of lubrication 164
Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. 160
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 160
Lubrication during colonoscopy: a forgotten factor. 157
Routine duodenal biopsies: is it time to change our minds? 155
Patient-reported outcomes in patients with endocrine tumors of the Ileum 155
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 154
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 154
Characterization of neuroendocrine pancreatic cancer with multidetector computer tomography and magneti resonance. 152
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 152
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs 151
Ipotesi di percorso diagnostico terapeutico dei tumori del pancreas. 150
Long-term survival in neuroendocrine tumors of the pancreas. 150
Warm water and oil assistance in colonoscopy 150
Neuroendocrine tumor of the pancreas and GIST: is there a correlation? 146
Multiple gastric endocrine tumors and gastrinomas of the duodenum in a patient with a ZES MEN I 146
WHO-2010 and WHO-2000 classifications for pancreatic endocrine tumors. Is it time to change ? 146
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases 145
Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. 145
CRITICAL ANALYSIS ON MANAGEMENT OF GIST PATIENTS WITH EVENT TREE MODEL 145
Oil-lubricated colonoscopy: easier and less painful? 144
Warm water or oil-assisted colonoscopy: toward simpler examinations? 144
Maffucci syndrome with hemangioma of the liver 144
Warm water and oil for the difficult colon 144
Sedation on demand and lubrication during colonoscopy: should we change our mind ? 143
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 142
Treatment of Zollinger-Ellison Syndrome 142
Neuroendocrine tumor of the pancreas and GIST: is there a correlation ? 141
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study. 139
Quality of life in chronic pancreatitis. 139
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 139
Lymph Node Ratio as a Prognostic Factor in Patients with Pancreatic Endocrine Tumours JOP 139
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 136
Characterization of neuroendocrine pancreatic cancer with multidetector computed tomography and magnetic resonance. 133
Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis? 131
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 131
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. 130
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. 130
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 129
Everolimus for advanced pancreatic neuroendocrine tumors. 127
68Ga-DOTA-NOC and 18F-DOPA PET in the evaluation of patients with neuroendocrine tumours. 124
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of (90) Y-DOTA-D-Phe1-Tyr3 octreotide. 124
Management of acute pancreatitis: current knowledge and future perspectives. 123
Neuroendocrine Tumours with Secondary Liver Lesions 121
Surgical treatment of non-functioning pancreatic islet cell tumors 120
Neoplasie endocrine del pancreas: follow-up clinico e terapeutico. In Attualità in pancreatologia. 120
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al. 120
Risk and Protective Factors for Small Intestine Neuroendocrine Tumours: A Prospective Case-Control Study 120
The search of the stool and blood K-ras mutations in patients with pancreatic mass. 119
PET/CT with 68Gallium-DOTA-peptides in NET: an overview. 119
Factors related to long-term survival in patients affected by well-differentiated endocrine tumors of the pancreas. ISRN Surg. 389385. [IF: 2.000] 119
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. 119
Warm water or oil-assisted colonoscopy: toward simpler examination ? 119
Benign pancreatic hyperenzymemia: Lights on a clinical challenge 119
null 117
WHO 2010 and WHO 2000 Classification: From a Sensitive Analysis to Reality 115
Medical Therapy of Malabsorption in Patients with Head Pancreatic Resection 115
Contrast-enhanced ultrasound in the differential diagnosis between esocrine and endocrine solid tumors of the pancreas. 110
PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS 108
Are there prognostics factors related to recurrence in neuroendocrine pancreatic tumors ? 108
Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas 106
Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors. 105
Functional imaging of digestive endocrine tumors. 104
Oil-lubricated colonoscopy: a new technique for easier examination? 98
Neoplasie endocrine del pancreas: follow-up clinico e terapeutico. 98
Somatostatin analogues: The state of the art. 96
The search of the stool and blood K-ras mutations in patients with pancreatic mass. A prospective study. 90
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 90
Surgical treatment of non-functioning islet cell tumors. 88
Totale 15.247
Categoria #
all - tutte 43.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021473 0 0 0 0 0 0 0 0 0 0 0 473
2021/20221.885 224 67 115 159 149 100 35 114 50 74 501 297
2022/20231.874 195 285 91 224 148 129 43 75 317 58 162 147
2023/2024439 40 89 41 47 51 74 21 16 17 18 7 18
2024/20251.782 38 351 165 111 433 87 130 40 6 84 11 326
2025/20264.313 424 439 410 291 497 230 369 215 778 322 149 189
Totale 15.763